首页 正文

Pemetrexed in second line of non-small cell lung cancer

{{output}}
Non small cell lung cancer (NSCLC), which is the leading cause of cancer mortality, is accounts for 85% of all cases of lung cancer. The majority of NSCLC patients present with advanced, unresectable disease. In advanced disease, chemotherapy with platinun (ci... ...